Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.4161/nucl.32235

http://scihub22266oqcxt.onion/10.4161/nucl.32235
suck pdf from google scholar
C4164484!4164484 !25482194
unlimited free pdf from europmc25482194
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25482194 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid25482194
      Nucleus 2014 ; 5 (5 ): 402-26
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Nucleolar stress with and without p53 #MMPMID25482194
  • James A ; Wang Y ; Raje H ; Rosby R ; DiMario P
  • Nucleus 2014[Sep]; 5 (5 ): 402-26 PMID25482194 show ga
  • A veritable explosion of primary research papers within the past 10 years focuses on nucleolar and ribosomal stress, and for good reason: with ribosome biosynthesis consuming ~80% of a cell's energy, nearly all metabolic and signaling pathways lead ultimately to or from the nucleolus. We begin by describing p53 activation upon nucleolar stress resulting in cell cycle arrest or apoptosis. The significance of this mechanism cannot be understated, as oncologists are now inducing nucleolar stress strategically in cancer cells as a potential anti-cancer therapy. We also summarize the human ribosomopathies, syndromes in which ribosome biogenesis or function are impaired leading to birth defects or bone narrow failures; the perplexing problem in the ribosomopathies is why only certain cells are affected despite the fact that the causative mutation is systemic. We then describe p53-independent nucleolar stress, first in yeast which lacks p53, and then in other model metazoans that lack MDM2, the critical E3 ubiquitin ligase that normally inactivates p53. Do these presumably ancient p53-independent nucleolar stress pathways remain latent in human cells? If they still exist, can we use them to target >50% of known human cancers that lack functional p53?
  • |Apoptosis/genetics [MESH]
  • |Cell Cycle Checkpoints/genetics [MESH]
  • |Cell Nucleolus/*genetics [MESH]
  • |Humans [MESH]
  • |Mutation [MESH]
  • |Neoplasms/genetics/therapy [MESH]
  • |Protein Biosynthesis/genetics [MESH]
  • |Proto-Oncogene Proteins c-mdm2/genetics [MESH]
  • |Ribosomes/*genetics [MESH]
  • |Signal Transduction/genetics [MESH]
  • |Stress, Physiological/*genetics [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box